98% of Cosmetic and Health Products Confirmed to Meet Quality Standards

The director general of cosmetics and health products at the Food and Drug Organization announced that more than 98% of the tested cosmetic and health products conform to laboratory quality control benchmarks.

According to the report of Ambassador Arjan Mahmoud Alboyeh, at the 8th Iran Cosmetics Exhibition, describing the supervisory measures of the Food and Drug Organization, he said: Sampling of the products in the market and their examination in official, reliable and standard laboratories is one of the continuous actions of the deputy food and drug agencies throughout the country, which is carried out in the framework of the post-marketing monitoring program (PMC).

He added: In 1404, nearly 8,000 cosmetic and health products were sampled and tested, and more than 98% of them were in an acceptable state in terms of laboratory quality control indicators.

Referring to the results of the review of product labels, the director general of cosmetics and health products of the Food and Drug Organization said: The information included on the box, label and brochure of the products must be in accordance with the legal requirements and in such a way that the necessary information is clearly provided to the consumer. Based on the investigations, the label content of 92% of the products was favorable and 8% was unfavorable.

Al-Boye asked the technical officials of the companies to improve the condition of the products by cooperating in correcting the labels and to refrain from including content that causes the consumer to misunderstand or exaggerate the effects and features of the product.

He emphasized: the real quality of the product is the most important factor in gaining the trust of the consumer and the introduction of the products should be done based on their features and real performance.

Referring to the results of the examination of the child lock in the products subject to this requirement, Al Boyeh stated: In more than 99% of the selected samples, the requirements related to the child lock were met, which indicates the favorable cooperation of the manufacturers in implementing these requirements.

Explaining the supervisory approach of the Food and Drug Organization, he said: monitoring of products is done based on risk assessment; This means that as the risk of a product increases, the number of samplings and the frequency of checking its compliance with legal requirements also increases. This prioritization does not mean abandoning other products, and other products are also reviewed and monitored according to the facilities.

The Director General of Cosmetics and Health Affairs of the Food and Drug Organization further pointed to the statistics of IRC issuance and said: In 1404, about 5,800 IRCs were issued in the import sector and more than 21,000 IRCs were issued for domestically produced products. In 1405, until the presentation of statistics, about 2 thousand IRCs were issued in the import sector and about 96 thousand IRCs were issued in the field of domestic production.

He stated: continuous monitoring of product quality, labeling review, assessment of compliance with safety requirements and risk-based monitoring are the main axes of monitoring cosmetic and health products.